Comparative full-length sequence analysis of oncogenic and vaccine (Rispens) strains of Marek's disease virus

Journal of General Virology

Volumn 88, Issue 4, 2007, Pages 1080-1096

  Spatz, Stephen J ^a   Petherbridge, Lawrence ^b   Zhao, Yuguang ^b   Nair, Venugopal ^b  

^a AGRICULTURAL RESEARCH SERVICE   (United States)

^b INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN MEQ; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; AVIAN LYMPHOMATOSIS HERPETOVIRUS; BASE PAIRING; DNA SEQUENCE; EMBRYO; GENE INSERTION; GENETIC ORGANIZATION; INVERTED REPEAT; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SEROTYPE; SINGLE NUCLEOTIDE POLYMORPHISM; STRAIN DIFFERENCE; VIRUS GENOME; VIRUS STRAIN; VIRUS VIRULENCE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; BASE SEQUENCE; CODON, NONSENSE; DNA, VIRAL; GENE ORDER; GENES, VIRAL; GENOME, VIRAL; MARDIVIRUS; MOLECULAR SEQUENCE DATA; MUTATION; OPEN READING FRAMES; PHYLOGENY; RECOMBINATION, GENETIC; REPETITIVE SEQUENCES, NUCLEIC ACID; SELECTION (GENETICS); SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; VIRAL PROTEINS; VIRAL VACCINES;

GALLID HERPESVIRUS 2;

EID: 34047159975     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.82600-0     Document Type: Article

References (77)

1. Anderson, A. S., Francesconi, A. & Morgan, R. W. (1992). Complete nucleotide sequence of the Marek's disease virus ICP4 gene. Virology 189, 657-667.
2. Anobile, J. M., Arumugaswami, V., Downs, D., Czymmek, K., Parcells, M. & Schmidt C. J. (2006). Nuclear localization and dynamic properties of the Marek's disease virus oncogene products Meq and Meq/vIL8. J Virol 80, 1160-1166.
3. Besemer, J. & Borodovsky, M. (2005). GeneMark: web software for gene finding in prokaryotes, eukaryotes and viruses. Nucleic Acids Res 33, W451-W454.
4. Blaho, J. A., Mitchell, C. & Roizman, B. (1994). An amino acid sequence shared by the herpes simplex virus 1 alpha regulatory proteins 0, 4, 22, and 27 predicts the nucleotidylylation of the UL21, UL31, UL47, and UL49 gene products. J Biol Chem 269, 17401-17410.
5. Calnek, B. W. (2001). Pathogenesis of Marek's disease virus infection. Curr Top Microbiol Immunol 255, 25-55.
6. Chang, K. S., Lee, S. I., Ohashi, K., Ibrahim, A. & Onuma, M. (2002a). The detection of the meq gene in chicken infected with Marek's disease virus serotype 1. J Vet Med Sci 64, 413-417.
7. Chang, K. S., Ohashi, K & Onuma, M. (2002b). Diversity (polymorphism) of the meq gene in the attenuated Marek's disease virus (MDV) serotype 1 and MDV-transformed cell lines. J Vet Med Sci 64, 1097-1101.
8. Chang, K. S., Ohashi, K. & Onuma, M. (2002c). Suppression of transcription activity of the MEQ protein of oncogenic Marek's disease virus serotype 1 (MDV1) by L-MEQ of non-oncogenic MDV1. J Vet Med Sci 64, 1091-1095.
9. Churchill, A. E., Payne, L. N. & Chubb, R. C. (1969). Marek's disease immunization against Marek's disease using a live attenuated virus. Lancet i, 610-611.
10. Cohrs, R. J., Gilden, D. H., Gomi, Y., Yamanishi, K. & Cohen, J. I. (2006). Comparison of virus transcription during lytic infection of the Oka parental and vaccine strains of varicella-zoster virus. J Virol 80, 2076-2082.
11. Corpet, F. (1988). Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res 16, 10881-10890.
12. Cortes, P. L. & Cardona, C. J. (2004). Pathogenesis of a Marek's disease virus mutant lacking vIL-8 in resistant and susceptible chickens. Avian Dis 48, 50-60.
13. Cui, X., Lee, L. F., Reed, W. M., Kung, H. J. & Reddy, S. M. (2004). Marek's disease virus-encoded vIL-8 gene is involved in early cytolytic infection but dispensable for establishment of latency. J Virol 78, 4753-4760.
14. Cui, X., Lee, L. F., Hunt, H. D., Reed, W. M., Lupiani, B. & Reddy, S. M. (2005). A Marek's disease virus vIL-8 deletion mutant has attenuated virulence and confers protection against challenge with a very virulent plus strain. Avian Dis 49, 199-206.
15. Davison, F. & Nair, V. (2005). Use of Marek's disease vaccines: could they be driving the virus to increasing virulence? Expert Rev Vaccines 4, 77-88.
16. Dorange, F., El Mehdaoui, S., Pichon, C., Coursaget, P. & Vautherot, J.-F. (2000). Marek's disease virus (MDV) homologues of herpes simplex virus type 1 UL49 (VP22) and UL48 (VP16) genes: high-level expression and characterization of MDV-1 VP22 and VP16. J Gen Virol 81, 2219-2230.
17. Dorange, F., Tischer, B. K., Vautherot J. F. & Osterrieder, N. (2002). Characterization of Marek's disease virus serotype 1 (MDV-1) deletion mutants that lack UL46 to UL49 genes: MDV-1 UL49, encoding VP22, is indispensable for virus growth. J Virol 76, 1959-1970.
18. Elliott, G., O'Reilly, D. & O'Hare, P. (1999). Identification of phosphorylation sites within the herpes simplex virus tegument protein VP22. J Virol 73, 6203-6206.
19. Fragnet, L., Blasco, M. A., Klapper, W. & Rasschaert, D. (2003). The RNA subunit of telomerase is encoded by Marek's disease virus. J Virol 77, 5985-5996.
20. Gimeno, I. M., Witter, R. L., Hunt, H. D., Reddy, S. M., Lee, L. F. & Silva, R. F. (2005). The pp38 gene of Marek's disease virus (MDV) is necessary for cytolytic infection of B cells and maintenance of the transformed state but not for cytolytic infection of the feather follicle epithelium and horizontal spread of MDV. J Virol 79, 4545-4549.
21. Gomi, Y., Sunamachi, H., Mori, Y., Nagaike, K., Takahashi, M. & Yamanishi, K. (2002). Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus. J Virol 76, 11447-11459.
22. Gonzales, M. J., Dugan, J. M. & Shafer, R. W. (2002). Synonymous-non-synonymous mutation rates between sequences containing ambiguous nucleotides (Syn-SCAN). Bioinformatics 18, 886-887.
23. Hong, Y. & Coussens, P. M. (1994). Identification of an immediate-early gene in the Marek's disease virus long internal repeat region which encodes a unique 14-kilodalton polypeptide. J Virol 68, 3593-3603.
24. Jarosinski, K. W. & Schat, K A. (2007). Multiple alternative splicing to exons II and III of viral interleukin-8 (vIL-8) in the Marek's disease virus genome: the importance of vIL-8 exon I. Virus Genes 34, 9-22.
25. Jarosinski, K. W., Osterrieder, N., Nair, V. K. & Schat, K. A. (2005). Attenuation of Marek's disease virus by deletion of open reading frame RLORF4 but not RLORF5a. J Virol 79, 11647-11659.
26. Jones, D., Lee, L., Liu, J.-L., Kung, H.-J. & Tillotson, J. K. (1992). Marek's disease virus encodes a basic-leucine zipper gene resembling the fos/jun oncogenes that is highly expressed in lymphoblastoid tumors. Proc Natl Acad Sci U S A 89, 4042-4046.
27. Jons, A., Gerdts, V., Lange, E., Kaden, V. & Mettenleiter, T. C. (1997). Attenuation of dUTPase-deficient pseudorabies virus for the natural host. Vet Microbiol 56, 47-54.
28. Jukes, T. H. & Cantor, C. R. (1969). Evolution of protein molecules. In Mammalian Protein Metabolism, pp. 21-132. Edited by H. N. Munro. New York: Academic Press.
29. Kaiser, P., Hughes, S. & Bumstead, N. (1999). The chicken 9E3/CEF4 CXC chemokine is the avian orthologue of IL8 and maps to chicken chromosome 4 syntenic with genes flanking the mammalian chemokine cluster. Immunogenetics 49, 673-684.
30. Kamil, J. P., Tischer, B. K., Trapp, S., Nair, V. K., Osterrieder, N. & Kung, H. J. (2005). vLIP, a viral lipase homologue, is a virulence factor of Marek's disease virus. J Virol 79, 6984-6996.
31. Katoh, K., Kuma, K., Toh, H. & Miyata, T. (2005). MAFFT version 5: improvement in accuracy of multiple sequence alignment. Nucleic Acids Res 33, 511-518.
32. Kattenhorn, L. M., Korbel, G. A., Kessler, B. M., Spooner, E. & Ploegh, H. L. (2005). A deubiquitinating enzyme encoded by HSV-1 belongs to a family of cysteine proteases that is conserved across the family Herpesviridae. Mol Cell 19, 547-557.
33. Kay, B. K., Williamson, M. P. & Sudol, M. (2000). The importance of being proline: the interaction of proline-rich motifs in signaling proteins with their cognate domains. FASEB J 14, 231-241.
34. Klupp, B. G., Fuchs, W., Granzow, H., Nixdorf, R. & Mettenleiter, T. C. (2002). Pseudorabies virus UL36 tegument protein physically interacts with the UL37 protein. J Virol 76, 3065-3071.
35. Koppers-Lalic, D., Reits, E. A., Ressing, M. E., Lipinska, A. D., Abele, R., Koch, J., Marcondes Rezende, M., Admiraal, P., van Leeuwen, D. & other authors (2005). Varicelloviruses avoid T cell recognition by UL49.5-mediated inactivation of the transporter associated with antigen processing. Proc Natl Acad Sci U S A 102, 5144-5149.
36. Kumar, S., Tamura, K. & Nei, M. (2004). MEGA3: integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment. Brief Bioinform 5, 150-163.
37. Laurent, S., Esnault, E. & Rasschaert, D. (2004). Single-nucleotide polymorphisms in two Marek's disease virus genes (Meq and gD): application to a retrospective molecular epidemiology study (1982-1999) in France. J Gen Virol 85, 1387-1392.
38. Lee, L. F., Wu, P., Sui, D., Ren, D., Kamil, J., Kung, H. J. & Witter, R. L. (2000a). The complete unique long sequence and the overall genomic organization of the GA strain of Marek's disease virus. Proc Natl Acad Sci U S A 97, 6091-6096.
39. Lee, S. I., Takagi, M., Ohashi, K., Sugimoto, C. & Onuma, M. (2000b). Difference in the meq gene between oncogenic and attenuated strains of Marek's disease virus serotype 1. J Vet Med Sci 62, 287-292.
40. Levy, A. M., Izumiya, Y., Brunovskis, P., Xia, L., Parcells, M. S., Reddy, S. M., Lee, L., Chen, H. W. & Kung, H. J. (2003). Characterization of the chromosomal binding sites and dimerization partners of the viral oncoprotein Meq in Marek's disease virus-transformed T cells. J Virol 77, 12841-12851.
41. Lipinska, A. D., Koppers-Lalic, D., Rychlowski, M., Admiraal, P., Rijsewijk, F. A., Bienkowska-Szewczyk, K. & Wiertz, E. J. (2006). Bovine herpesvirus 1 UL49.5 protein inhibits the transporter associated with antigen processing despite complex formation with glycoprotein M. J Virol 80, 5822-5832.
42. Liu, J. L. & Kung, H. J. (2000). Marek's disease herpesvirus transforming protein MEQ: a c-Jun analogue with an alternative life style. Virus Genes 21, 51-64.
43. Liu, J. L., Lin, S. F., Xia, L., Brunovskis, P., Li, D., Davidson, I., Lee, L. F. & Kung, H. J. (1999). MEQ and V-IL8: cellular genes in disguise? Acta Virol 43, 94-101.
44. Lupiani, B., Lee, L. F. & Reddy, S. M. (2001). Protein-coding content of the sequence of Marek's disease virus serotype 1. Curr Top Microbiol Immunol 255, 159-190.
45. Lupiani, B., Lee, L. F., Cui, X., Gimeno, I., Anderson, A., Morgan, R. W., Silva, R. F., Witter, R. L., Kung, H. J. & Reddy, S. M. (2004). Marek's disease virus-encoded Meq gene is involved in transformation of lymphocytes but is dispensable for replication. Proc Natl Acad Sci U S A 101, 11815-11820.
46. McNabb, D. S. & Courtney, R. J. (1992). Analysis of the UL36 open reading frame encoding the large tegument protein (ICP1/2) of herpes simplex virus type 1. J Virol 66, 7581-7584.
47. Nair, V. (2005). Evolution of Marek's disease - a paradigm for incessant race between the pathogen and the host. Vet J 170, 175-183.
48. Niikura, M., Liu, H. C., Dodgson, J. B. & Cheng, H. H. (2004). A comprehensive screen for chicken proteins that interact with proteins unique to virulent strains of Marek's disease virus. Poult Sci 83, 1117-1123.
49. Niikura, M., Dodgson, J. & Cheng, H. (2006). Direct evidence of host genome acquisition by the alphaherpesvirus Marek's disease virus. Arch Virol 151, 537-549.
50. Nishiyama, Y. (2004). Herpes simplex virus gene products: the accessories reflect her lifestyle well. Rev Med Virol 14, 33-46.
51. Osterrieder, K. & Vautherot, J.-F. (2004). The genome content of Marek's disease-like viruses. In Marek's Disease: an Evolving Problem, pp. 17-31. Edited by F. Davison & V. Nair. Oxford: Elsevier.
52. Pagliusi, S. R. & Teresa Aguado, M. (2004). Efficacy and other milestones for human papillomavirus vaccine introduction. Vaccine 23, 569-578.
53. Parcells, M. S., Lin, S. F., Dienglewicz, R. L., Majerciak, V., Robinson, D. R., Chen, H. C., Wu, Z., Dubyak, G. R., Brunovskis, P. & other authors (2001). Marek's disease virus (MDV) encodes an interleukin-8 homolog (vIL-8): characterization of the vIL-8 protein and a vIL-8 deletion mutant MDV. J Virol 75, 5159-5173.
54. Peng, O. & Shirazi, Y. (1996a). Characterization of the protein product encoded by a splicing variant of the Marek's disease virus Eco-Q gene (Meq). Virology 226, 77-82.
55. Peng, O. & Shirazi, Y. (1996b). Isolation and characterization of Marek's disease virus (MDV) cDNAs from a MDV-transformed lymphoblastoid cell line: identification of an open reading frame antisense to the MDV Eco-Q protein (Meq). Virology 221, 368-374.
56. Peng, O., Zeng, M., Bhuiyan, Z. A., Ubukata, E., Tanaka, A., Nonoyama, M. & Shirazi, Y. (1995). Isolation and characterization of Marek's disease virus (MDV) cDNAs mapping to the BamHI-I2, BamHI-Q2, and BamHI-L fragments of the MDV genome from lymphoblastoid cells transformed and persistently infected with MDV. Virology 213, 590-599.
57. Petherbridge, L., Howes, K., Baigent, S. J., Sacco, M. A., Evans, S., Osterrieder, N. & Nair, V. (2003). Replication-competent bacterial artificial chromosomes of Marek's disease virus: novel tools for generation of molecularly defined herpesvirus vaccines. J Virol 77, 8712-8718.
58. Phelan, A., Elliott, G. & O'Hare, P. (1998). Intercellular delivery of functional p53 by the herpesvirus protein VP22. Nat Biotechnol 16, 440-443.
59. Prince, A. M. (1996). Prevention of liver cancer and cirrhosis by vaccines. Clin Lab Med 16, 493-505.
60. Qian, Z., Brunovskis, P., Lee, L., Vogt, P. K. & Kung, H. J. (1996). Novel DNA binding specificities of a putative herpesvirus bZIP oncoprotein. J Virol 70, 7161-7170.
61. Rispens, B. H., van Vloten, H., Mastenbroek, N., Maas, H. J. & Schat, K. A. (1972). Control of Marek's disease in the Netherlands. I. Isolation of an avirulent Marek's disease virus (strain CVI 988) and its use in laboratory vaccination trials. Avian Dis 16, 108-125.
62. Schaffer, A. A., Aravind, L., Madden, T. L., Shavirin, S., Spouge, J. L., Wolf, Y. I., Koonin, E. V. & Altschul, S. F. (2001). Improving the accuracy of PSI-BLAST protein database searches with composition-based statistics and other refinements. Nucleic Acids Res 29, 2994-3005.
63. Schat, K. A. & Calnek, B. W. (1978). Characterizations of an apparently non-oncogenic Mareks disease virus. J Natl Cancer Inst 60, 1075-1082.
64. Schlieker, C., Korbel, G. A., Kattenhorn, L. M. & Ploegh, H. L. (2005). A deubiquitinating activity is conserved in the large tegument protein of the herpesviridae. J Virol 79, 15582-15585.
65. Shamblin, C. E., Greene, N., Arumugaswami, V., Dienglewicz, R. L. & Parcells, M. S. (2004). Comparative analysis of Marek's disease virus (MDV) glycoprotein-, lytic antigen pp38- and transformation antigen Meq-encoding genes: association of meq mutations with MDVs of high virulence. Vet Microbiol 102, 147-167.
66. Silva, R. F., Lee, L. F. & Kutish, G. F. (2001). The genomic structure of Marek's disease virus. Curr Top Microbiol Immunol 255, 143-158.
67. Spatz, S. J. & Silva, R. F. (2007). Polymorphisms in the repeat long regions of oncogenic and attenuated pathotypes of Marek's disease virus 1. Virus Genes (in press). doi:10.1007/s11262-006-0024-5
68. Staden, R., Beal, K. F. & Bonfield, J. K. (2000). The Staden package, 1998. Methods Mol Biol 132, 115-130.
69. Tischer, B. K., Schumacher, D., Messerle, M., Wagner, M. & Osterrieder, N. (2002). The products of the UL10 (gM) and the UL49.5 genes of Marek's disease virus serotype 1 are essential for virus growth in cultured cells. J Gen Virol 83, 997-1003.
70. Trapp, S., Parcells, M. S., Kamil, J. P., Schumacher, D., Tischer, B. K., Kumar, P. M., Nair, V. K. & Osterrieder, N. (2006). A virus-encoded telomerase RNA promotes malignant T cell lymphoma-genesis. J Exp Med 203, 1307-1317.
71. Tulman, E. R., Afonso, C. L., Lu, Z., Zsak, L., Rock, D. L. & Kutish, G. F. (2000). The genome of a very virulent Marek's disease virus. J Virol 74, 7980-7988.
72. Vittone, V., Diefenbach, E., Triffett, D., Douglas, M. W., Cunningham, A. L. & Diefenbach, R. J. (2005). Determination of interactions between tegument proteins of herpes simplex virus type 1. J Virol 79, 9566-9571.
73. Witter, R. L. (1997). Increased virulence of Marek's disease virus field isolates. Avian Dis 41, 149-163.
74. Witter, R. L. (2001a). Marek's disease virus vaccines - past, present and future (chicken vs. virus - a battle of the centuries). In Current Progress on Marek's Disease Research. Proceedings of the 6th International Symposium on Marek's Disease, pp. 1-9. Edited by K. A. Schat, R. M. Morgan, M. S. Parcells & J. L. Spencer. Kennett Square, PA: American Association of Avian Pathologists.
75. Witter, R. L. (2001b). Protective efficacy of Marek's disease vaccines. Curr Top Microbiol Immunol 255, 57-90.
76. Witter, R. L., Nazerian, K., Purchase, H. G. & Burgoyne, G. H. (1970). Isolation from turkeys of a cell-associated herpesvirus antigenically related to Marek's disease virus. Am J Vet Res 31, 525-538.
77. Zarrinpar, A., Bhattacharyya, R. P. & Lim, W. A. (2003). The structure and function of proline recognition domains. Sci STKE 2003, RE8.